跳至主要内容
临床试验/ISRCTN25778550
ISRCTN25778550已完成Unknown

Effect of esketamine-based opioid reduction anesthesia on postoperative nausea and vomiting in patients undergoing laparoscopic radical resection of colorectal cancer

Changzhou Science and Technology Bureau0 个研究点目标入组 84 人开始时间: 2024年9月26日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
84
主要终点
The occurrence and intensity of postoperative nausea and vomiting (PONV) measured using the PONV Impact Scale at 1, 24, and 48 h after surgery

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients undergoing laparoscopic radical resection of colorectal cancer
  • Aged 18-80 years old, no gender limitation
  • Postoperative agreed to use the PCIA
  • Voluntarily signed informed consent

排除标准

  • People with severe consciousness disorder or mental system disease and cognitive dysfunction
  • Merge heart liver and kidney and other viscera function disorder
  • Arrhythmia (atrial fibrillation or atrioventricular conduction block between arrhythmia etc.) or after cardiac pacemaker implantation
  • BP or 180/100 MMHG, untreated or poor control of blood pressure
  • Increased intracranial pressure
  • Without treatment, and treatment of hyperthyroidism
  • Known for esketamine injection, the active ingredient or complementary makings allergies
  • Alcohol or alcohol addiction
  • Have a vision, hearing, or language barrier and cannot communicate and cooperate

结局指标

主要结局

The occurrence and intensity of postoperative nausea and vomiting (PONV) measured using the PONV Impact Scale at 1, 24, and 48 h after surgery

次要结局

未报告次要终点

研究者

发起方
Changzhou Science and Technology Bureau

相似试验

Esketamine for reducing perioperative opioid use in... | 临床试验